Y Chromosome Sequences Reveal a Short Beringian Standstill, Rapid Expansion, and early Population structure of Native American Founders.


Journal

Current biology : CB
ISSN: 1879-0445
Titre abrégé: Curr Biol
Pays: England
ID NLM: 9107782

Informations de publication

Date de publication:
07 01 2019
Historique:
received: 03 05 2018
revised: 03 09 2018
accepted: 09 11 2018
pubmed: 26 12 2018
medline: 24 1 2020
entrez: 25 12 2018
Statut: ppublish

Résumé

The Americas were the last inhabitable continents to be occupied by humans, with a growing multidisciplinary consensus for entry 15-25 thousand years ago (kya) from northeast Asia via the former Beringia land bridge [1-4]. Autosomal DNA analyses have dated the separation of Native American ancestors from the Asian gene pool to 23 kya or later [5, 6] and mtDNA analyses to ∼25 kya [7], followed by isolation ("Beringian Standstill" [8, 9]) for 2.4-9 ky and then a rapid expansion throughout the Americas. Here, we present a calibrated sequence-based analysis of 222 Native American and relevant Eurasian Y chromosomes (24 new) from haplogroups Q and C [10], with four major conclusions. First, we identify three to four independent lineages as autochthonous and likely founders: the major Q-M3 and rarer Q-CTS1780 present throughout the Americas, the very rare C3-MPB373 in South America, and possibly the C3-P39/Z30536 in North America. Second, from the divergence times and Eurasian/American distribution of lineages, we estimate a Beringian Standstill duration of 2.7 ky or 4.6 ky, according to alternative models, and entry south of the ice sheet after 19.5 kya. Third, we describe the star-like expansion of Q-M848 (within Q-M3) starting at 15 kya [11] in the Americas, followed by establishment of substantial spatial structure in South America by 12 kya. Fourth, the deep branches of the Q-CTS1780 lineage present at low frequencies throughout the Americas today [12] may reflect a separate out-of-Beringia dispersal after the melting of the glaciers at the end of the Pleistocene.

Identifiants

pubmed: 30581024
pii: S0960-9822(18)31495-7
doi: 10.1016/j.cub.2018.11.029
pii:
doi:

Substances chimiques

DNA, Ancient 0
DNA, Mitochondrial 0

Banques de données

Dryad
['10.5061/dryad.h38853n']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-157.e3

Subventions

Organisme : Wellcome Trust
ID : 098051
Pays : United Kingdom

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Thomaz Pinotti (T)

Laboratório de Biodiversidade e Evolução Molecular (LBEM), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos 6627, 31270-010 Belo Horizonte, Brazil; The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Anders Bergström (A)

The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Maria Geppert (M)

Institute of Legal Medicine and Forensic Sciences, Department of Forensic Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Matt Bawn (M)

Centro de Genética y Biología Molecular (CGBM), Instituto de Investigación, Facultad de Medicina Humana, Universidad de San Martin de Porres, 15009 Lima, Peru; The Earlham Institute, NR4 7UG Norwich, UK.

Dominique Ohasi (D)

Laboratório de Biodiversidade e Evolução Molecular (LBEM), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos 6627, 31270-010 Belo Horizonte, Brazil.

Wentao Shi (W)

The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, 300070 Tianjin, China.

Daniela R Lacerda (DR)

Laboratório de Biodiversidade e Evolução Molecular (LBEM), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos 6627, 31270-010 Belo Horizonte, Brazil.

Arne Solli (A)

Q Nordic Independent Researchers; Department of Archaeology, History, Cultural Studies and Religion (AHKR), University of Bergen, Norway.

Jakob Norstedt (J)

Q Nordic Independent Researchers.

Kate Reed (K)

Q Nordic Independent Researchers.

Kim Dawtry (K)

Q Nordic Independent Researchers.

Fabricio González-Andrade (F)

Translational Medicine Unit, Central University of Ecuador, Faculty of Medical Sciences, Iquique N14-121 y Sodiro-Itchimbía, Sector El Dorado, 170403 Quito, Ecuador.

Cesar Paz-Y-Miño (C)

Universidad de las Americas, Av. de los Granados E12-41, 170513 Quito, Ecuador.

Susana Revollo (S)

Universidad Mayor de San Andrés, Av. Villazón 1995, 2008 La Paz, Bolivia.

Cinthia Cuellar (C)

Universidad Mayor de San Andrés, Av. Villazón 1995, 2008 La Paz, Bolivia.

Marilza S Jota (MS)

Laboratório de Biodiversidade e Evolução Molecular (LBEM), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos 6627, 31270-010 Belo Horizonte, Brazil.

José E Santos (JE)

Laboratório de Biodiversidade e Evolução Molecular (LBEM), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos 6627, 31270-010 Belo Horizonte, Brazil.

Qasim Ayub (Q)

The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; Monash University Malaysia Genomics Facility, Tropical Medicine and Biology Multidisciplinary Platform, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia; School of Science, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia.

Toomas Kivisild (T)

Department of Archaeology and Anthropology, University of Cambridge, CB2 1QH Cambridge, UK; Estonian Biocentre, 51010 Tartu, Estonia.

José R Sandoval (JR)

Centro de Genética y Biología Molecular (CGBM), Instituto de Investigación, Facultad de Medicina Humana, Universidad de San Martin de Porres, 15009 Lima, Peru.

Ricardo Fujita (R)

Centro de Genética y Biología Molecular (CGBM), Instituto de Investigación, Facultad de Medicina Humana, Universidad de San Martin de Porres, 15009 Lima, Peru.

Yali Xue (Y)

The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Lutz Roewer (L)

Institute of Legal Medicine and Forensic Sciences, Department of Forensic Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Fabrício R Santos (FR)

Laboratório de Biodiversidade e Evolução Molecular (LBEM), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos 6627, 31270-010 Belo Horizonte, Brazil. Electronic address: fsantos@icb.ufmg.br.

Chris Tyler-Smith (C)

The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. Electronic address: cts@sanger.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH